Bictegravir/Emtricitabine/Tenofovir Alafenide Plus Doravirine
NCT04538040
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
HIV-1-infection
Interventions
DRUG:
Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch
Sponsor
Quest Clinical Research
Collaborators
[object Object]